IL164266A0 - Treatment of gastroparesis - Google Patents
Treatment of gastroparesisInfo
- Publication number
- IL164266A0 IL164266A0 IL16426603A IL16426603A IL164266A0 IL 164266 A0 IL164266 A0 IL 164266A0 IL 16426603 A IL16426603 A IL 16426603A IL 16426603 A IL16426603 A IL 16426603A IL 164266 A0 IL164266 A0 IL 164266A0
- Authority
- IL
- Israel
- Prior art keywords
- gastroparesis
- treatment
- Prior art date
Links
- 206010021518 Impaired gastric emptying Diseases 0.000 title 1
- 208000001288 gastroparesis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37165002P | 2002-04-10 | 2002-04-10 | |
PCT/US2003/008457 WO2003087139A2 (en) | 2002-04-10 | 2003-03-27 | Treatment of gastroparesis |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164266A0 true IL164266A0 (en) | 2005-12-18 |
Family
ID=29250714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16426603A IL164266A0 (en) | 2002-04-10 | 2003-03-27 | Treatment of gastroparesis |
Country Status (18)
Country | Link |
---|---|
US (1) | US20050164925A1 (pt) |
EP (1) | EP1496924A4 (pt) |
JP (1) | JP2005530732A (pt) |
KR (1) | KR20040098063A (pt) |
CN (1) | CN1735423A (pt) |
AU (1) | AU2003220403A1 (pt) |
BR (1) | BR0308904A (pt) |
CA (1) | CA2480858A1 (pt) |
EA (1) | EA200401345A1 (pt) |
EC (1) | ECSP045345A (pt) |
HR (1) | HRP20040939A2 (pt) |
IL (1) | IL164266A0 (pt) |
MX (1) | MXPA04009929A (pt) |
NO (1) | NO20044815L (pt) |
NZ (1) | NZ535684A (pt) |
PL (1) | PL373658A1 (pt) |
WO (1) | WO2003087139A2 (pt) |
ZA (1) | ZA200408111B (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
JP2007537981A (ja) | 2003-09-19 | 2007-12-27 | ノボ ノルディスク アクティーゼルスカブ | 新規の血漿タンパク質親和性タグ |
SI2932981T1 (sl) * | 2003-09-19 | 2021-11-30 | Novo Nordisk A/S | Albumin-vezavni derivati GLP-1 |
US8612016B2 (en) | 2004-08-18 | 2013-12-17 | Metacure Limited | Monitoring, analysis, and regulation of eating habits |
EP1880298B1 (en) | 2005-02-17 | 2016-07-13 | Metacure Limited | Charger with data transfer capabilities |
US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
AU2006224537A1 (en) | 2005-03-18 | 2006-09-21 | Novo Nordisk A/S | Extended GLP-1 compounds |
TWI372629B (en) | 2005-03-18 | 2012-09-21 | Novo Nordisk As | Acylated glp-1 compounds |
WO2007080595A2 (en) | 2006-01-12 | 2007-07-19 | Metacure N.V. | Electrode assemblies, tools, and methods for gastric wall implantation |
ATE533403T1 (de) * | 2005-03-24 | 2011-12-15 | Metacure Ltd | Drahtlose leitungen für magen-darm-trakt- anwendungen |
US8301256B2 (en) | 2005-06-02 | 2012-10-30 | Metacure Limited | GI lead implantation |
US8442841B2 (en) * | 2005-10-20 | 2013-05-14 | Matacure N.V. | Patient selection method for assisting weight loss |
US8295932B2 (en) | 2005-12-05 | 2012-10-23 | Metacure Limited | Ingestible capsule for appetite regulation |
CA2648936C (en) * | 2006-04-20 | 2013-07-09 | Amgen Inc. | Glp-1 compounds |
AU2012203915B9 (en) * | 2006-04-20 | 2014-10-09 | Amgen Inc. | GLP-1 compounds |
EP2150308B1 (en) * | 2007-05-09 | 2018-08-08 | MetaCure Limited | Analysis and regulation of food intake |
US8423130B2 (en) * | 2008-05-09 | 2013-04-16 | Metacure Limited | Optimization of thresholds for eating detection |
WO2010015668A1 (en) | 2008-08-06 | 2010-02-11 | Novo Nordisk A/S | Conjugated proteins with prolonged in vivo efficacy |
WO2010084173A1 (en) | 2009-01-22 | 2010-07-29 | Novo Nordisk Health Care Ag | Stable growth hormone compounds |
JP6086528B2 (ja) | 2009-08-06 | 2017-03-01 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 長期のインビボ有効性を有する成長ホルモン |
EP2482840A4 (en) * | 2009-08-07 | 2013-06-26 | Mannkind Corp | VAL (8) GLP-1 COMPOSITION AND METHOD FOR THE TREATMENT OF REAGENTS AND / OR IRRITATION SYNDROME |
AU2011208620B2 (en) | 2010-01-22 | 2015-04-16 | Novo Nordisk Health Care Ag | Stable growth hormone compounds |
KR101813595B1 (ko) | 2010-01-22 | 2017-12-29 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 장기적 생체 내 효능을 갖는 성장 호르몬 |
WO2011092710A2 (en) * | 2010-02-01 | 2011-08-04 | Metacure Limited | Gastrointestinal electrical therapy |
WO2011136361A1 (ja) | 2010-04-30 | 2011-11-03 | 株式会社 三和化学研究所 | 生理活性物質等の生体内安定性向上のためのペプチド及び生体内安定性が向上した生理活性物質 |
UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
AU2013360721A1 (en) | 2012-12-21 | 2015-07-09 | Sanofi | Exendin-4 Derivatives as dual GLP1/GIP or trigonal GLP1/GIP/Glucagon Agonists |
JP6464145B2 (ja) | 2013-04-05 | 2019-02-06 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 成長ホルモン化合物製剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6268343B1 (en) * | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
JP2002510193A (ja) * | 1997-03-31 | 2002-04-02 | イーライ・リリー・アンド・カンパニー | グルカゴン様ペプチド−1類似体 |
IL142707A0 (en) * | 2000-04-27 | 2002-03-10 | Pfizer Prod Inc | Methods of treating obesity using a neurotensin receptor ligand |
-
2003
- 2003-03-27 US US10/508,762 patent/US20050164925A1/en not_active Abandoned
- 2003-03-27 IL IL16426603A patent/IL164266A0/xx unknown
- 2003-03-27 PL PL03373658A patent/PL373658A1/xx unknown
- 2003-03-27 EA EA200401345A patent/EA200401345A1/ru unknown
- 2003-03-27 NZ NZ535684A patent/NZ535684A/xx unknown
- 2003-03-27 AU AU2003220403A patent/AU2003220403A1/en not_active Abandoned
- 2003-03-27 CA CA002480858A patent/CA2480858A1/en not_active Abandoned
- 2003-03-27 BR BR0308904-5A patent/BR0308904A/pt not_active IP Right Cessation
- 2003-03-27 CN CNA038080079A patent/CN1735423A/zh active Pending
- 2003-03-27 KR KR10-2004-7016025A patent/KR20040098063A/ko not_active Application Discontinuation
- 2003-03-27 EP EP03716707A patent/EP1496924A4/en not_active Withdrawn
- 2003-03-27 MX MXPA04009929A patent/MXPA04009929A/es not_active Application Discontinuation
- 2003-03-27 WO PCT/US2003/008457 patent/WO2003087139A2/en not_active Application Discontinuation
- 2003-03-27 JP JP2003584094A patent/JP2005530732A/ja active Pending
-
2004
- 2004-10-07 ZA ZA200408111A patent/ZA200408111B/xx unknown
- 2004-10-07 HR HRP20040939 patent/HRP20040939A2/hr not_active Application Discontinuation
- 2004-10-08 EC EC2004005345A patent/ECSP045345A/es unknown
- 2004-11-05 NO NO20044815A patent/NO20044815L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20044815L (no) | 2005-01-07 |
CA2480858A1 (en) | 2003-10-23 |
MXPA04009929A (es) | 2006-03-10 |
ZA200408111B (en) | 2005-10-07 |
HRP20040939A2 (en) | 2004-12-31 |
EP1496924A4 (en) | 2007-05-30 |
BR0308904A (pt) | 2005-05-03 |
ECSP045345A (es) | 2006-04-19 |
EP1496924A2 (en) | 2005-01-19 |
WO2003087139A2 (en) | 2003-10-23 |
US20050164925A1 (en) | 2005-07-28 |
KR20040098063A (ko) | 2004-11-18 |
NZ535684A (en) | 2006-03-31 |
JP2005530732A (ja) | 2005-10-13 |
EA200401345A1 (ru) | 2005-08-25 |
CN1735423A (zh) | 2006-02-15 |
WO2003087139A3 (en) | 2004-01-08 |
AU2003220403A1 (en) | 2003-10-27 |
PL373658A1 (en) | 2005-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL164266A0 (en) | Treatment of gastroparesis | |
GB2393202B (en) | Methods of well treatment | |
IL218909A0 (en) | Treatment of diabetes | |
GB0213869D0 (en) | The treatment of pain | |
GB0211295D0 (en) | Treatment of pain | |
GB0124124D0 (en) | Methods of treatment | |
GB0306309D0 (en) | Method of treatment | |
GB0302572D0 (en) | Method of treatment | |
GB0210741D0 (en) | Methods of therapy | |
AP2004003174A0 (en) | Treatment of water | |
GB0221157D0 (en) | Novel treatment | |
GB0217493D0 (en) | Novel methods of treatment | |
GB0208897D0 (en) | New method of treatment | |
GB0221712D0 (en) | Methods of treatment | |
GB0327975D0 (en) | Methods of treatment | |
GB0213198D0 (en) | Method of treatment | |
GB0207091D0 (en) | Method of treatment | |
GB0223254D0 (en) | Methods of treatment | |
GB0208783D0 (en) | Methods of treatment | |
GB0229986D0 (en) | Treatment of materials | |
AU2003276123A8 (en) | Treatment of uveal melanoma | |
GB0221582D0 (en) | Method of treatment | |
GB0215583D0 (en) | Method of treatment | |
GB0206699D0 (en) | Method of treatment | |
GB0201281D0 (en) | Method of treatment |